KR880002525A - 뇌 허혈성 병을 수반하는 질환 치료제 - Google Patents

뇌 허혈성 병을 수반하는 질환 치료제

Info

Publication number
KR880002525A
KR880002525A KR1019870009346A KR870009346A KR880002525A KR 880002525 A KR880002525 A KR 880002525A KR 1019870009346 A KR1019870009346 A KR 1019870009346A KR 870009346 A KR870009346 A KR 870009346A KR 880002525 A KR880002525 A KR 880002525A
Authority
KR
South Korea
Prior art keywords
treatment
diseases involving
ischemic disease
brain ischemic
involving brain
Prior art date
Application number
KR1019870009346A
Other languages
English (en)
Other versions
KR950002151B1 (ko
Inventor
유끼후미 노다
히로유끼 나바따
Original Assignee
쥬우가이 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쥬우가이 세이야꾸 가부시끼가이샤 filed Critical 쥬우가이 세이야꾸 가부시끼가이샤
Publication of KR880002525A publication Critical patent/KR880002525A/ko
Application granted granted Critical
Publication of KR950002151B1 publication Critical patent/KR950002151B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
KR1019870009346A 1986-08-27 1987-08-26 뇌 허혈성 병을 수반하는 질환 치료제 KR950002151B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27
JP61-198796 1986-08-27

Publications (2)

Publication Number Publication Date
KR880002525A true KR880002525A (ko) 1988-05-09
KR950002151B1 KR950002151B1 (ko) 1995-03-14

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870009346A KR950002151B1 (ko) 1986-08-27 1987-08-26 뇌 허혈성 병을 수반하는 질환 치료제

Country Status (22)

Country Link
US (1) US4870090A (ko)
JP (1) JPH07121863B2 (ko)
KR (1) KR950002151B1 (ko)
AU (1) AU603375B2 (ko)
BE (1) BE1003959A5 (ko)
CA (1) CA1302888C (ko)
CH (1) CH672069A5 (ko)
DE (1) DE3728499A1 (ko)
DK (1) DK171392B1 (ko)
FI (1) FI873727A (ko)
FR (1) FR2605222B1 (ko)
GB (1) GB2195532B (ko)
HK (1) HK64993A (ko)
IE (1) IE60601B1 (ko)
IT (1) IT1211477B (ko)
LU (1) LU86973A1 (ko)
NL (1) NL8701994A (ko)
NO (1) NO873571L (ko)
NZ (1) NZ221564A (ko)
SE (1) SE502323C2 (ko)
SG (1) SG52393G (ko)
ZA (1) ZA876401B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
US6329349B1 (en) * 1997-10-23 2001-12-11 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) * 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
WO1987005508A1 (en) * 1986-03-14 1987-09-24 Medical College Of Wisconsin Research Foundation, Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
ZA876401B (en) 1988-04-27
JPH07121863B2 (ja) 1995-12-25
CA1302888C (en) 1992-06-09
BE1003959A5 (fr) 1992-07-22
FR2605222B1 (fr) 1991-02-22
NZ221564A (en) 1999-08-30
IE872218L (en) 1988-02-27
CH672069A5 (ko) 1989-10-31
DK171392B1 (da) 1996-10-14
FI873727A0 (fi) 1987-08-27
JPS63152317A (ja) 1988-06-24
US4870090A (en) 1989-09-26
NO873571D0 (no) 1987-08-24
IT1211477B (it) 1989-11-03
NO873571L (no) 1988-02-29
AU7731187A (en) 1988-03-03
IT8767725A0 (it) 1987-08-21
SE8703308D0 (sv) 1987-08-26
DE3728499A1 (de) 1988-03-03
FI873727A (fi) 1988-02-28
FR2605222A1 (fr) 1988-04-22
SE8703308L (sv) 1988-02-28
GB2195532A (en) 1988-04-13
AU603375B2 (en) 1990-11-15
SG52393G (en) 1993-08-06
HK64993A (en) 1993-07-16
KR950002151B1 (ko) 1995-03-14
DK441987D0 (da) 1987-08-25
DK441987A (da) 1988-02-28
IE60601B1 (en) 1994-07-27
SE502323C2 (sv) 1995-10-02
NL8701994A (nl) 1988-03-16
GB2195532B (en) 1990-05-23
LU86973A1 (fr) 1987-12-16
GB8720219D0 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
DE3885049D1 (de) Zubereitung zur Hautpflege.
DK217188D0 (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK412289D0 (da) Praeparat til anvendelse ved saarheling
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
KR890004737A (ko) 질병 치료용 자석
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
KR900700442A (ko) 신규 부정맥 치료제 i
DE3884966D1 (de) Mittel zur behandlung der ischämischen gehirnkrankheit.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DK250088D0 (da) Ophthalmologisk praeparat
DK28188D0 (da) Medicinsk diagnoseapparat
KR880002525A (ko) 뇌 허혈성 병을 수반하는 질환 치료제
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DK373688A (da) Behandlingsmetode
DK140588A (da) Terapeutisk nucleosider
YU22186A (en) Process for obtaining compound for healing skin disease psoriazis
IT8848344A0 (it) Dispositivo per il trattamento delle malattie delle gengive
ATE95696T1 (de) Mittel zur behandlung der ischaemischen gehirnkrankheit.
KR890006382U (ko) 혈액 순환용 지압밴드
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
KR880021422U (ko) 환자용 침대
DK681288A (da) Aenootropt terapeutisk laegemiddelae
NO892195D0 (no) Fosfatidylbehandling av virussykdom.
UA24956A (uk) Спосіб хірургічhого лікуваhhя ішемічhої хвороби серця

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20021226

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee